NMPA Releases 61st Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 61st batch of reference drugs for...
Policy / Regulatory
Shaanxi Releases Notice for Inter-Provincial Orthodontic Brackets VBP
The Shaanxi Public Resources Trading Center has released the “Inter-provincial Alliance (regions, Corps) Orthodontic Brackets...
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
The National Healthcare Security Administration (NHSA) has responded to the No. 6184 suggestion from the...
NHSA Completes Expert Review for NRDL Price Negotiation Process
The National Healthcare Security Administration (NHSA) has released a notification indicating that the expert review...
CDE Releases Draft Guidelines for Extrapolating Adult Drug Data to Pediatric Use
The Center for Drug Evaluation (CDE) has released the “Guidelines on Quantitative Methodology for Extrapolating...
Azvudine Included in China’s COVID-19 Treatment Protocol
The National Healthcare Commission and the National Administration of Traditional Chinese Medicine have released a...
Shanghai Launches High-Quality Development Pilot for Public Hospitals
The Shanghai Municipal Health Commission (SHC) has released a notification regarding the public hospital high-quality...
NMPA Introduces Electronic Certificates for Biologics and Narcotic Drugs
The National Medical Products Administration (NMPA) has released a notification regarding the initiation of electronic...
CDE Releases Draft Guidelines for Tumor Therapeutic Vaccine Clinical Trials
The Center for Drug Evaluation (CDE) has released the “Tumor Therapeutic Vaccines Clinical Trial Technical...
CDE Releases 63rd Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 63rd batch of chemical generic reference...
Jiangsu Launches Sunshine Procurement Platform for Drugs and Medical Consumables
Jiangsu province has launched its drugs and medical consumables sunshine procurement services website, providing a...
WuXi Biologics Removed from US Unverified List Amid Ongoing Restrictions
The US Commerce Department’s Bureau of Industry and Security (BIS) has updated its Unverified List...
India Launches Anti-Dumping Investigation Against Chinese Imports of Metronidazole
The Union Ministry of Commerce and Industry in India has initiated an anti-dumping investigation into...
China’s NMPA Proposes Reforms to Enhance Radiopharmaceutical Review and Approval
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Opinions on Reforming...
China’s NMPA Releases 60th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 60th batch of reference drugs for...
China’s Volume-Based Procurement Cuts High-Value Medical Consumables Costs by 84%
The national high-value medical consumables alliance procurement office has released the results of the third...
BGI Genomics Added to US Defense Department’s Investment Ban List
BGI Genomics Co., Ltd, a leading Chinese gene sequencing firm, has reportedly been added to...
NHSA Releases Guide on Volume-Based Procurement Drug Equivalents
The National Healthcare Security Administration (NHSA) has reportedly released a reference guide for industry players,...
F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review
UK-based biotech F-star Therapeutics Inc. (NASDAQ: FSTX) announced in a stock exchange press release that...
Heilongjiang Launches ‘Longjiang Huiminbao’ Supplementary Health Insurance Scheme
Heilongjiang province has launched its first provincial-level supplementary commercial health insurance scheme, branded “Longjiang Huiminbao.”...